Report proposes approach to opioid prescribing guidelines for acute pain
A new from the National Academies of Sciences, Engineering, and Medicine recommends two frameworks that medical professional societies, health care organizations, and state, national and local agencies could use to develop clinical practice guidelines for prescribing opioids to manage acute pain. Requested by the Food and Drug Administration, the report also identifies surgical procedures and acute medical conditions for which evidence-based guidelines would be desirable. Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research, the agency will consider the recommendations as it develops evidence-based prescribing guidelines for treating acute pain in therapeutic areas for which guidelines do not exist.
Related News Articles
Headline
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride…
Headline
The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports…
Headline
The Food and Drug Administration has issued alerts for issues with certain catheters made by BD and Conavi. BD identified an increase in material fatigue…
Headline
The AHA Living Learning Network is launching the Quality Exchange, a virtual collaborative for health care quality and patient safety professionals at…
Headline
As part of the AHA's Patient Safety Initiative, a dedicated webpage features case studies showing how hospitals and health systems across the nation are…
Headline
The Food and Drug Administration has identified a Class I recall of Medtronic Aortic Root Cannulas due to a risk of unexpected loose material in the male luer…